FDA Inspection 1053505 — Silgan Unicep Packaging, LLC
The FDA completed an inspection of Silgan Unicep Packaging, LLC on May 25, 2018 in Sandpoint, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sandpoint, ID (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1450 | 21 CFR 211.113(a) | Procedures for non-sterile drug products |
| 3623 | 21 CFR 211.170(a) | Active ingredient retained sample kept |